MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro
- PMID: 23890123
- PMCID: PMC3854706
- DOI: 10.1186/scrt247
MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro
Abstract
Introduction: Resistance of cancer stem/progenitor cells (CSPCs) to chemotherapy can lead to cancer relapse. Ovarian teratocarcinoma (OVTC) arises from germ cells and comprises pluripotent cells that can be used to study cancer cell stemness. In this study, we evaluated whether microRNA-21 (miR-21) promotes ovarian teratocarcinoma by maintaining cancer stem/progenitor populations.
Methods: The lentiviral delivery system was used to upregulate or to suppress the expression of miR-21 in the human ovarian teratocarcinoma cell line PA1 and cell growth assays were used to monitor the expression of miR-21 at different time points. Antibodies directed toward CD133, a stem cell marker, were used to identify CSPCs in the PA1 cell population, and the level of miR-21 expression was determined in enriched CSPCs. Stem cell functional assays (sphere assay and assays for CD133 expression) were used to assess the effects of miR-21 on progression of the CD133+ population.
Results: Knockdown of miR-21 in PA1 cells attenuated growth of PA1 cells whereas overexpression of miR-21 promoted cell growth. Moreover, knockdown of miR-21 resulted in a marked reduction in the CD133+ population and sphere formation of CSPCs. In contrast, overexpression of miR-21 resulted in a marked increase in the population of CD133+ cells as well as sphere formation of CSPCs.
Conclusions: MicroRNA-21 plays a significant role in cancer growth by regulating stemness in cancer cells.
Figures





Comment in
-
MicroRNA-21 regulates stemness in cancer cells.Stem Cell Res Ther. 2013;4(5):110. doi: 10.1186/scrt321. Stem Cell Res Ther. 2013. PMID: 24041029 Free PMC article.
Similar articles
-
Ligand-independent androgen receptors promote ovarian teratocarcinoma cell growth by stimulating self-renewal of cancer stem/progenitor cells.Stem Cell Res. 2014 Jul;13(1):24-35. doi: 10.1016/j.scr.2014.04.003. Epub 2014 Apr 15. Stem Cell Res. 2014. PMID: 24793306
-
MicroRNA-21 regulates stemness in cancer cells.Stem Cell Res Ther. 2013;4(5):110. doi: 10.1186/scrt321. Stem Cell Res Ther. 2013. PMID: 24041029 Free PMC article.
-
MiR-1207 overexpression promotes cancer stem cell-like traits in ovarian cancer by activating the Wnt/β-catenin signaling pathway.Oncotarget. 2015 Oct 6;6(30):28882-94. doi: 10.18632/oncotarget.4921. Oncotarget. 2015. PMID: 26337084 Free PMC article.
-
miR-3120-5p promotes colon cancer stem cell stemness and invasiveness through targeting Axin2.Biochem Biophys Res Commun. 2018 Feb 5;496(2):302-308. doi: 10.1016/j.bbrc.2018.01.021. Epub 2018 Jan 4. Biochem Biophys Res Commun. 2018. PMID: 29307822
-
microRNA and stem cell function.Cell Tissue Res. 2008 Jan;331(1):57-66. doi: 10.1007/s00441-007-0530-3. Epub 2007 Nov 7. Cell Tissue Res. 2008. PMID: 17987317 Free PMC article. Review.
Cited by
-
Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors.Cancer Drug Resist. 2024 Feb 28;7:6. doi: 10.20517/cdr.2023.152. eCollection 2024. Cancer Drug Resist. 2024. PMID: 38434767 Free PMC article. Review.
-
miRNA nanotherapeutics for cancer.Drug Discov Today. 2017 Feb;22(2):424-432. doi: 10.1016/j.drudis.2016.10.014. Epub 2016 Nov 1. Drug Discov Today. 2017. PMID: 27815139 Free PMC article. Review.
-
Human epididymis protein 4 expression positively correlated with miR-21 and served as a prognostic indicator in ovarian cancer.Tumour Biol. 2016 Jun;37(6):8359-65. doi: 10.1007/s13277-015-4672-8. Epub 2016 Jan 5. Tumour Biol. 2016. PMID: 26733162
-
In-Tether Chiral Center Induced Helical Peptide Modulators Target p53-MDM2/MDMX and Inhibit Tumor Growth in Stem-Like Cancer Cell.Theranostics. 2017 Oct 13;7(18):4566-4576. doi: 10.7150/thno.19840. eCollection 2017. Theranostics. 2017. PMID: 29158845 Free PMC article.
-
Androgen receptor mitigates postoperative disease progression of hepatocellular carcinoma by suppressing CD90+ populations and cell migration and by promoting anoikis in circulating tumor cells.Oncotarget. 2016 Jul 19;7(29):46448-46465. doi: 10.18632/oncotarget.10186. Oncotarget. 2016. PMID: 27340775 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials